Teva Pharmaceutical Industries Ltd. (TEVJF)
37.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Teva Pharmaceutical Industries Price to Book Value : 5.560 for Sept. 2, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 5.560 |
| September 01, 2026 | 5.560 |
| August 31, 2026 | 5.560 |
| August 28, 2026 | 5.560 |
| August 27, 2026 | 5.560 |
| August 26, 2026 | 5.560 |
| August 25, 2026 | 5.560 |
| August 24, 2026 | 5.560 |
| August 21, 2026 | 5.560 |
| August 20, 2026 | 5.560 |
| August 19, 2026 | 5.560 |
| August 18, 2026 | 5.560 |
| August 17, 2026 | 5.560 |
| August 14, 2026 | 5.560 |
| August 13, 2026 | 5.560 |
| August 12, 2026 | 5.560 |
| August 11, 2026 | 4.268 |
| August 10, 2026 | 4.268 |
| August 07, 2026 | 4.268 |
| August 06, 2026 | 4.268 |
| August 05, 2026 | 4.268 |
| August 04, 2026 | 4.268 |
| August 03, 2026 | 4.268 |
| July 31, 2026 | 4.268 |
| July 30, 2026 | 4.268 |
| Date | Value |
|---|---|
| July 29, 2026 | 4.268 |
| July 28, 2026 | 4.268 |
| July 27, 2026 | 4.268 |
| July 24, 2026 | 4.268 |
| July 23, 2026 | 4.268 |
| July 22, 2026 | 4.268 |
| July 21, 2026 | 4.268 |
| July 20, 2026 | 4.959 |
| July 17, 2026 | 4.959 |
| July 16, 2026 | 4.959 |
| July 15, 2026 | 4.959 |
| July 14, 2026 | 4.959 |
| July 13, 2026 | 4.959 |
| July 10, 2026 | 4.959 |
| July 09, 2026 | 4.959 |
| July 08, 2026 | 4.959 |
| July 07, 2026 | 4.959 |
| July 06, 2026 | 4.959 |
| July 02, 2026 | 4.959 |
| July 01, 2026 | 4.959 |
| June 30, 2026 | 4.559 |
| June 29, 2026 | 4.292 |
| June 26, 2026 | 4.292 |
| June 25, 2026 | 4.292 |
| June 24, 2026 | 4.292 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 4.730 |
| Purple Biotech Ltd. | 0.2611 |
| Sol-Gel Technologies Ltd. | 4.794 |
| PolyPid Ltd. | 19.98 |
Price to Book Value Related Metrics
| PE Ratio | 61.69 |
| PS Ratio | 2.497 |
| Price to Free Cash Flow | 15.87 |
| Price | 37.00 |
| Earnings Yield | 1.62% |
| Market Cap | 43.10B |
| Operating PE Ratio | 13.26 |
| Normalized PE Ratio | 23.35 |